Only Adymite
Medical Device
First Adymite
Artificial Disc
Born from
Diamonds
Request More Info
10
Jul

Dymicron Granted IDE Approval for Triadyme-C Artificial Disc

0

Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to begin a pivotal clinical study of the Triadyme®‑C cervical artificial disc. This achievement marks a critical milestone in the company’s mission to bring the next-generation cervical artificial disc to patients suffering from degenerative disc disease.

About the author

Recent Comments

    Categories

    Stay Connected for the Latest from Dymicron

    Sign up to discover the latest news about Dymicron and our proprietary polycrystalline diamond technology–Adymite. Adymite is redefining performance and reliability in spinal disc replacement, including delivering unmatched durability and excellent long-term outcomes for patients.